Close menu

November 1st, 2021 | 14:12 CET

BYD, BrainChip, Volkswagen: Insider tip on the megatrend of autonomous driving

  • Technology
Photo credits:

German city centers are regularly congested and overcrowded. One of the reasons for city crowding is thousands of cars parked in the morning only to sit around all day. Given the price per square meter in big cities, that seems pretty inefficient. The fact that electric cars are often only economically and environmentally viable after many thousands of kilometers also suggests that they should be used differently today. Autonomous driving could be the key to mobility that gives people more space in the city, avoids traffic jams and even lowers the cost of mobility. We outline three exciting titles around the topic.

time to read: 3 minutes | Author: Nico Popp

Table of contents:

    BYD: Here is what happens now

    The fact that commuting to work every day is anything but ideal is particularly evident on Chinese streets. Rents in the city are high; people often commute several hours to their workplace and are primarily stuck in traffic jams. Chinese automaker BYD is one of the beneficiaries of the Chinese officials' realization that things cannot go on like this. Years ago, China already limited the number of registrations for classic internal combustion vehicles in many urban centers. However, this limit did not apply to electric cars. In this way, the country wanted to combat pollution and smog in large cities. Although the air in Chinese metropolises is still bad today, it is hard to imagine the situation without electric cars.

    Governments and administrations could soon develop new ideas around autonomous driving: If individual automobile traffic were regulated and autonomous driving solutions were favored instead, the parking problem in many inner cities would be solved abruptly. The autonomous shuttles could bring commuters into the city and immediately pick up additional passengers, transport goods, or drive to the countryside for loading or inspections. Within cities, parking lots could be landscaped, and parking garages could be used for more profitable construction - space in cities is scarce, after all. Chinese carmaker BYD has recently come under pressure due to weak figures, but the Company is perfectly prepared to benefit from the next mobility revolution. BYD manufactures electric cars and has its own chip production. In addition, BYD operates in a market that is predestined to promote innovations around autonomous driving politically and administratively due to the general conditions, such as bad air and daily traffic jams. BYD remains an extremely exciting share, though it is already the talk of the town.

    BrainChip: Revolutionary chip technology for autonomous driving

    More of an insider tip is the Australian company BrainChip. The Company is developing a revolutionary chip based on the human brain in terms of its structure and functionality. It has great significance for practical applications. In addition to extremely low energy consumption, Akida has artificial intelligence built-in, so to speak: even when the chip is installed, it is capable of learning. This learning manifests itself in gradually decreasing latencies and also lowering power consumption. Like the human brain, the chip from BrainChip also functions comparatively autonomously - Akida does not need an Internet connection. Analysts at Pitt Street Research see Akida as a revolutionary achievement because the chip solves three problems related to AI applications: it requires only low bandwidths and low power, and it scores with low latency.

    Areas of application for Akida are expected to be autonomous driving and applications around the Internet of Things. The first batch of the chip rolled off the production line in Taiwan in August. The manufacturing partner is TSMC. Now it is a matter of BrainChip working with its partners to make customers aware of the chip. Analysts at Pitt Street Research expect that initial collaborations in this area could be a catalyst that significantly boosts the stock. The analysts see the fair value for BrainChip shares at AUD 1.50 - the stock is currently trading at around one-third.

    Volkswagen: Preparations for the next mobility revolution

    One of the companies that would undoubtedly find a presentation of the Akida chip interesting is Volkswagen. The carmaker already made the turn toward electromobility some time ago. A few months ago, the Company from Lower Saxony also swallowed the car rental company Europcar. Behind this is a strategy that many automakers have been quietly pursuing for years: The development toward becoming a mobility provider. Trends such as autonomous driving could make the Company's own vehicle obsolete. To keep in touch with the end customer nonetheless, today's car rental companies could become tomorrow's mobility providers. A mileage package in a monthly subscription. A permanent subscription for the daily commute or an all-round carefree flat rate including a family van, SUV or city car as required - if autonomous driving changes the way we get around, such visions could become a reality.

    At present, however, Volkswagen, like many automakers, is suffering from a chip shortage. The good prospects for e-cars seem to be priced in. BYD is in a better position; the Company shines with its chips and promising opportunities in China. BrainChip has what it takes to make the achievements of the future possible - with all the positive consequences. The stock is still a speculative venture, but the product is considered extremely promising.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Armin Schulz on October 4th, 2022 | 10:58 CEST

    JinkoSolar, TubeSolar, Encavis - Shares for the energy turnaround

    • agritech
    • renewableenergies
    • Technology

    The phase-out of fossil energy generation is a done deal in Germany, but there is still a long way to go. Germany's share of renewable energies in electricity generation was 42.4% in 2021. However, this covered only 19.7% of Germany's energy consumption. Since the flare-up of the Ukraine crisis, the expansion of renewable energies is to be accelerated. A balanced mix is essential. Spring and summer are the main times for solar power, while in fall and winter, when the days are shorter, wind power is the primary source of electricity. If we want to achieve the 2030 targets, a massive expansion is essential. Today we take a look at three renewable energy companies.


    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...


    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.